Veterinary CRO & CDMO Market Size is valued at USD 1475.63 Mn in 2024 and is predicted to reach USD 118868.03 Mn by the year 2034 at 55.2% CAGR during the forecast period for 2025-2034.
Both Veterinary CROs and CDMOs play a collaborative role in advancing veterinary medicine, offering expertise, resources, and infrastructure that enable the efficient and effective development of new treatments and health products for animals. By partnering with these organizations, veterinary product developers can accelerate the time to market for new therapies, contributing to animal health and welfare while also addressing the needs of the veterinary market. These organizations provide a variety of services, including preclinical and clinical studies, regulatory support, formulation development, and commercial-scale manufacturing of veterinary pharmaceuticals. The veterinary CRO and CDMO industry has expanded significantly due to rising demand for safe and effective veterinary pharmaceuticals, the requirement for regulatory compliance, and increased investment in animal healthcare. These organizations play a critical role in veterinary pharmaceutical development, ensuring their safety and efficacy, and assisting corporations in navigating the veterinary industry's complex regulatory structure.
The veterinary CRO and CDMO market is being pushed by rising awareness of animal health and welfare, severe regulatory requirements, and a need for specialized services. Rising pet ownership, improved livestock production, and the prevalence of zoonotic diseases have all contributed to increased investment in veterinary pharmaceutical research and development. Stringent safety and efficacy criteria have increased demand for specialized services. Advances in veterinary medicine and technology have offered prospects for novel medicines, accelerating market growth. Pharmaceutical companies and CRO/CDMOs can collaborate strategically to create drugs at a lower cost and with greater efficiency. Overall, these aspects contribute to the market's growth.
The Veterinary CRO & CDMO Market is segmented by animal type, application type and service type,. Based on animal type, the market is segrigated into companion and livestock animals. By application type, the market is segmented into medicine and medical devices. By service type, the market is segmented into discovery, development, manufacturing, packaging & labeling, and market approval & post-marketing.
The livestock animal segment led the business in 2022, accounting for 40.4% of total revenue because to the high production rate of vaccinations, medicines, and infectious disease diagnostic goods aimed primarily at food-producing animals. The dominant share is also attributed to rising protein consumption, milk or meat requirements, and expanding live animal markets worldwide. Furthermore, rising zoonotic concerns and increased spending on livestock animals are driving the demand for CROs and CDMOs to support huge medication production.
The medical devices segment is estimated to increase at the quickest CAGR throughout the forecast period. Rising technical breakthroughs in veterinary diagnostics, rising animal healthcare expenditure, and the widespread availability of contract veterinary equipment manufacturers and raw material suppliers are driving segment expansion. Furthermore, corporations are investing more in expanding their production capacity through the use of broad networks of CROs and CDMOs, which has a beneficial impact on and supports subsequent growth rates.
North America dominated the animal health CRO & CDMO market, accounting for more than 30% of total revenue. This considerable share can be attributable to the strong presence of important companies coupled with the rising number of drug development and veterinary product launch activities in the region. Rising veterinary clinical trial activities in the United States, increased availability of contract organizations in veterinary product development, improved manufacturing infrastructure in the region's developed countries, and increasing animal healthcare investments all contribute to market growth. The Asia Pacific area would exhibit the quickest CAGR during the predicted period. This is primarily due to the region's attractiveness, as well as the low-cost and flexible sourcing provided by large networks of veterinary outsourcing companies. Countries, like China and India, have been dominating in medical outsourcing for some years; moreover, recently, Southeast Asian countries, like Philippines, Malaysia, Indonesia, and Vietnam, are garnering market attention with significant potential. Similarly, popular destinations for veterinary outsourcing activities include Latin America, the Middle East, and Africa.
|
Report Attribute |
Specifications |
|
Growth Rate CAGR |
CAGR of 55.2% from 2025 to 2034 |
|
Quantitative Units |
Representation of revenue in US$ Bn and CAGR from 2025 to 2034 |
|
Historic Year |
2021 to 2024 |
|
Forecast Year |
2025-2034 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Animal Type, Application Type, Service Type |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; Southeast Asia; South Korea |
|
Competitive Landscape |
Aare Labcorp Drug Development, Charles River Laboratories, Clinvet, Klifovet GmbH, Oncovet Clinical Research (OCR), Knoell Triveritasm, Vetspin, Inotiv, Idexx Laboratories, Zoetis Nexvet, PAREXEL International Corporation, ICON plc, Pharmaceutical Product Development, LLC (PPD), Syneos Health, WuXi AppTec, Medpace, Envigo, Vetio Animal Health, Clinipace, MPI Research, Veterinary Research Management (VRM), VetPharm, Inc., Merck Animal Health and others. |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Veterinary CRO & CDMO Market By Animal Type -
Veterinary CRO & CDMO Market By Application Type -
Veterinary CRO & CDMO Market By Service Type -
Veterinary CRO & CDMO Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
